【Exp.2025/100%AUTHENTIC】 Nourkrin HAIR GROWTH+ INCLINIC 90 Tablets

Hair Growth+ inCLINIC by Nourkrin® is a scientifically developed Proteoglycan Replacement Therapy formulated to help maintain a normal Hair Growth Cycle, supporting normal healthy hair growth.
60% of women and 80% of men will experience hair loss at some stage in their lives. No matter the hair loss cause, the Hair Growth Cycle is always negatively affected.
Several factors can influence the healthy Hair Growth Cycle and disrupt normal hair growth, resulting in a negative cycle of increased shedding, with weak or no re-growth at all. By utilising a Proteoglycan Replacement Therapy, which is rich in specific bioactive proteoglycans, the hair follicles can be induced back into the growth phase and begin a new revitalised Hair Growth Cycle, leading to increased hair density and quality.
Hair Growth+ inCLINIC is the global leading, completely drug-free, safe, side effect free formulation, based on natural ingredients.
Hair Growth+ inCLINIC is the result of more than 100 scientific studies and clinical papers, as well as several consumer studies published in leading peer-reviewed journals over the last 30 years.
Hair Growth+ inCLINIC is made by Nourkrin®, the award-winning brand that is recognised by scientists, doctors, dermatologists and trichologists worldwide.
8 out of 10 women saw a significant improvement after taking Hair Growth+ inCLINIC by Nourkrin®.

TO ACTIVATE HAIR GROWTH:
Three tablets per day to be taken orally in divided doses preferably after food. Minimum duration of therapy is 4-6 months as prescribed or until satisfied with result. Thereafter a reduced-dose continuation therapy should be followed on the Maintenance dosage below.

TO MAINTAIN HAIR GROWTH:
One tablet per day to be taken orally preferably after food for an indefinite period of time. Should hair growth need an additional boost during this period then switch back to the Activation dosage above for the recommended minimum duration.

Minimum duration of therapy is 4-6 months. The first clinical effect will be observed after an average of 3 months of therapy.